Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Andermann syndrome (agenesis of the corpus callosum with peripheral neuropathy; MONDO:0000902) is a rare autosomal recessive neurodevelopmental disorder caused by biallelic variants in SLC12A6 (HGNC:10914), encoding the neuronal K⁺–Cl⁻ cotransporter KCC3. Clinically, affected individuals present with complete or partial agenesis of the corpus callosum, progressive motor and sensory demyelinating neuropathy, global developmental delay, hypotonia, seizures, scoliosis and variable facial diplegia (HP:0001274) ([PMID:20020398]). Disease onset is typically in infancy or early childhood, with survival often limited to the second or third decade.
Genetic evidence for SLC12A6 involvement in Andermann syndrome is robust. Biallelic SLC12A6 variants have been described in ≥8 unrelated probands from consanguineous and non-consanguineous families, including compound heterozygous missense and splice-site mutations (e.g., c.1616G>A (p.Gly539Asp)) and homozygous truncating alleles ([PMID:20020398], [PMID:22462673], [PMID:24341143], [PMID:30868738], [PMID:32765936], [PMID:39988558]). Segregation analysis in discordant sibships and multiple families confirms full concordance of biallelic SLC12A6 genotypes with the ACCPN phenotype.
The variant spectrum is heterogeneous, encompassing missense (e.g., c.1616G>A (p.Gly539Asp)), frameshift (c.571_572dup (p.Tyr192fs)), nonsense (c.3031C>T (p.Arg1011Ter)) and splice-site changes (c.1943+1G>T). Many alleles are private, although c.3031C>T recurs in non-French Canadian populations ([PMID:17893295]). No deep-intronic or structural variants have been reported to date. Carrier frequency is highest in founder populations but rare worldwide.
Functional studies demonstrate that truncating and missense mutations abrogate KCC3-mediated K⁺–Cl⁻ cotransport. Heterologous expression of frameshift and nonsense alleles in Xenopus laevis oocytes shows absent transport activity despite proper membrane glycosylation ([PMID:12368912]). A Slc12a6 knockout mouse recapitulates human locomotor deficits, peripheral neuropathy and sensorimotor gating defects. More recent work shows that the p.His371Arg missense protein is mislocalized to the cytoplasm, disrupting ion homeostasis and inducing cellular senescence ([PMID:39988558]).
Mechanistically, Andermann syndrome arises from loss-of-function of KCC3 leading to impaired neuronal volume regulation and abnormal axonal excitability. Protein interaction studies reveal that truncations disrupt binding to brain-type creatine kinase, further compromising transporter activation and membrane trafficking ([PMID:18566107]). Rescue of transporter localization by curcumin highlights potential therapeutic avenues ([PMID:21628467]).
In summary, the SLC12A6–ACCPN association meets ClinGen definitive criteria: multiple unrelated probands (≥8), consistent autosomal recessive segregation and extensive functional concordance. Molecular testing for SLC12A6 should be prioritized in patients with early-onset demyelinating neuropathy and callosal dysgenesis. Identification of pathogenic KCC3 variants directly informs diagnosis, prognosis and genetic counseling.
Gene–Disease AssociationDefinitiveMultiple unrelated families (≥8 probands) with AR segregation and concordant functional studies Genetic EvidenceStrong≥8 unrelated probands with biallelic SLC12A6 variants and segregation in sibships Functional EvidenceStrongXenopus oocyte assays and Slc12a6 knockout mouse recapitulate human phenotype; mislocalization and protein interaction defects demonstrated |